Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs Sells 36,261 Shares

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) Director Randy E. Dobbs sold 36,261 shares of the company’s stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This represents a 25.19 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Viemed Healthcare Price Performance

VMD opened at $8.85 on Friday. The stock has a fifty day simple moving average of $8.37 and a two-hundred day simple moving average of $7.54. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The company has a market cap of $344.59 million, a price-to-earnings ratio of 32.78 and a beta of 1.43. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $10.44.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The business had revenue of $58.00 million during the quarter.

Institutional Investors Weigh In On Viemed Healthcare

A number of institutional investors have recently modified their holdings of the stock. National Bank of Canada FI boosted its position in shares of Viemed Healthcare by 91.2% during the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after buying an additional 1,596 shares during the last quarter. Evernest Financial Advisors LLC purchased a new stake in shares of Viemed Healthcare during the second quarter valued at $66,000. Perkins Coie Trust Co purchased a new position in Viemed Healthcare in the third quarter worth about $73,000. PDT Partners LLC purchased a new position in Viemed Healthcare in the third quarter worth about $78,000. Finally, Victory Capital Management Inc. boosted its position in Viemed Healthcare by 21.1% in the second quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after purchasing an additional 2,226 shares during the last quarter. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Further Reading

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.